Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Accolade Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	18,528	14,422	7,313	7,592	8,214	2,085
Market Cap Growth	66.59%	97.22%	-3.68%	-7.58%	293.91%	353.56%
Enterprise Value	17,334	13,741	6,290	7,175	7,748	1,574
Last Close Price	278.35	217.20	109.31	113.28	122.57	30.19
PE Ratio	30.72	26.05	32.55	28.41	43.57	12.23
PS Ratio	6.55	5.37	3.50	3.21	3.78	1.11
PB Ratio	7.72	6.01	3.90	4.78	6.19	1.71
P/TBV Ratio	12.01	9.35	3.90	4.78	6.19	1.71
P/FCF Ratio	-	26.24	20.94	16.39	140.06	7.51
P/OCF Ratio	-	26.08	20.80	16.27	118.81	7.39
EV/Sales Ratio	6.13	5.11	3.01	3.03	3.56	0.84
EV/EBITDA Ratio	31.14	26.91	28.37	20.67	30.37	7.92
EV/EBIT Ratio	37.98	32.00	29.03	21.18	32.30	8.38
EV/FCF Ratio	-	25.01	18.01	15.49	132.10	5.67
Debt / Equity Ratio	0.04	0.04	0.05	0.04	-	0.06
Debt / EBITDA Ratio	0.17	0.18	0.38	0.17	-	0.34
Debt / FCF Ratio	-	0.17	0.26	0.13	-	0.25
Asset Turnover	-	1.09	1.01	1.32	1.33	1.20
Inventory Turnover	-	6.39	4.52	3.68	3.02	2.75
Quick Ratio	-	5.48	8.31	4.92	2.32	1.89
Current Ratio	-	6.22	10.42	5.97	4.04	2.98
Return on Equity (ROE)	-	25.91%	12.97%	18.32%	14.81%	14.64%
Return on Assets (ROA)	-	10.84%	6.57%	11.79%	9.13%	7.51%
Return on Capital (ROIC)	12.80%	12.05%	7.50%	14.23%	11.47%	9.54%
Return on Capital Employed (ROCE)	-	17.00%	10.90%	20.20%	17.50%	15.20%
Earnings Yield	3.28%	3.84%	3.07%	3.52%	2.30%	8.18%
FCF Yield	-	3.81%	4.78%	6.10%	0.71%	13.31%
Dividend Yield	0.92%	1.15%	1.83%	1.76%	1.31%	1.32%
Payout Ratio	-	23.90%	58.31%	-	55.58%	15.36%
Buyback Yield / Dilution	0.16%	-1.46%	-1.35%	-	-	-
Total Shareholder Return	1.08%	-0.31%	0.48%	1.76%	1.31%	1.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.